Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-04-28
2000-10-03
McKane, Joseph
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546144, 546150, 546139, 514310, C07D21714
Patent
active
061273813
ABSTRACT:
The invention relates to melanocortin receptor ligands and methods of using the ligands to alter or regulate the activity of a melanocortin receptor. The invention further relates to tetrahydroisoquinoline aromatic amines that function as melanocortin receptor ligands and as agents for controlling cytokine-regulated physiologic processes and pathologies, and combinatorial libraries thereof.
REFERENCES:
patent: 5010175 (1991-04-01), Rutter et al.
patent: 5182366 (1993-01-01), Huebner et al.
patent: 5288514 (1994-02-01), Ellman
patent: 5324483 (1994-06-01), Cody et al.
patent: 5420109 (1995-05-01), Suto et al.
patent: 5618791 (1997-04-01), Du
patent: 5726156 (1998-03-01), Girten et al.
patent: 5874443 (1999-02-01), Kiely et al.
patent: 5916899 (1999-06-01), Kiely et al.
Abou-Mohamed et al., "HP-228, a novel synthetic peptide, inhibits the induction of nitric oxide synthase in vivo but not in vitro," J. Pharmacology Experimental Therapeutics, 275:584-591 (1995).
Berge et al., "Pharmaceutical salts," J. Pharm. Sci., 66:1-19 (1977).
Castagnoli, "The condensation of succinic anhydride with benzylidinemethylamine. A stereoselective synthesis of trans- and cis-1-Methyl-4-carboxy-5-phenyl-2-pyrrolidinone." J. of Org. Chem., 34(10):3187-3189 (1969).
Catania and Lipton, ".alpha.-Melanocyte-Stimulating Hormone Peptides in Host Responese, From Basic Evidence to Human Research," Annals N.Y. Acad.Sci., 680:412-423 (1993).
Catania et al., "The Neuropeptide .alpha.-MSH Has Specific Receptros on Neutrophils and Reduces Chemotaxis In Vitro," Peptides, 17(4):675-679 (1996).
Chowdhary et al., "Localization of the human melanocortin-5 receptor gene (MC5R) to chromosome band 18p11.2 by fluorescence in situ hybridization," Cytogenet Cell Genet 68:79-81 (1995).
Coppola, Gary, "Novel heterocycles. 8. Fused isoquinolines derived from the reaction of homophthalic anhydride with cyclic imino ethers." J. Heterocyclic Chem., 18:767-770 (1981).
Cushman and Castagnoli, "The synthesis of trans-3-methylnicotine." J. Org. Chem., 37(8):1268-1271 (1972).
Cushman and Castagnoli, "Synthesis of pharmacologically active nitrogen analogs of the tetrahydrocannabinols." J. Org. Chem., 39(11):1546-1550 (1974).
Cushman and Castagnoli, "The condensation of succinic anhydrides with schiff bases. Scope and mechanism." J. Org. Chem., 36(22):3404-3406 (1971).
Cushman and Castagnoli, "A novel approach to the synthesis of nitrogen analogs of the tetrahydrocannabinols." J. Org. Chem., 38(3):440-448 (1973).
Cushman and Madaj, "A study and mechanistic interpretation of the electronic and steric effects that determine the stereochemical outcome of the reaction of schiff bases with homophthalic anhydride and a 3-phenylsuccinic anhydride." J. Org. Chem., 52(5):907-915 (1987).
Dooley et al., "Melanocortin receptor binding assay in rat brain homogenate: identification of tetrapeptide ligands from a combinatorial library," Society for Neuroscience 23:964 Abstract 383.18 (Aug. 21, 1997).
Dorr et al., "Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study," Life Sci., 58(20):1777-1784 (1996).
Fan et al., "Role of melanocortinergic neurons in feeding and the agouti obesity syndrome," Nature, 385:165-168 (1997).
Frandberg et al., "Glutamine.sup.235 and arginine.sup.272 in human melanocortin 5 receptor determines its low affinity to MSH," Biochem. Biophys. Res. Commun. 236:489-492 (1997).
Friedman, "The alphabet of weight control," Nature, 385:119-120 (1997).
Gallop et al., "Applications of Combinatorial Technologies to Drug Discovery. 1. Background and Peptide Combinatorial Libraries," J. Med. Chem., 37:1233-1251 (1994).
Gantz et al., "Molecular cloning, expression, and gene localization of a fourth melanocortin receptor," J. Biol. Chem. 268:15174-15179 (1993).
Gantz et al., "Molecular cloning of a novel melanocortin receptor," J. Biol. Chem. 268:8246-8250 (1993).
Gantz et al., "Molecular cloning, expression, and characterization of a fifth melanocortin receptor," Biochem. Biophys. Res. Commun. 200:1214-1220 (1994).
Goff and Zuckermann, "Solid-phase synthesis of highly substituted peptide 1(2H)-Isoquinolinones." J. Org. Chem., 60:5748-5749 (1995).
Gordon et al., "Application of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies, and future directions." J. of Med. Chem., 37(10):1385-1401 (1994).
Gura, "Obesity Sheds Its Secrets," Science, 275:751-753 (1997).
Haimova et al., "A highly stereoselective synthesis of 3,4-dihydro-1(2H)-isoquinolinones and 8-oxoberbines from homophthalic anhydrides and azomethines." Tetrahedron, 33:331-336 (1977).
Haskell-Luevano et al., "Binding and cAMP studies of melanotropin peptides with the cloned human peripheral melanocortin receptor, hMC1R," Biochem. Biophys. Res. Commun. 204:1137-1142 (1994).
Haskell-Luevano et al., "Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R," J. Med. Chem. 40:2133-2139 (1997).
Hotamisligil and Spiegelman, "Tumor necrosis factor .alpha.: A key component of the obesity-diabetes link," Diabetes, 43:1271-1278 (1994).
Hotamisligil et al., "Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha," J. Clin. Invest., 94:1543-1549 (1994).
Hotamisligil et al., "Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance," J. Clin. Invest., 95:2409-2415 (1995).
Houghten et al., "Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery." Nature, 354:84-86 (1991).
Huszar et al., "Targeted disruption of the melanocortin-4 receptor results in obesity in mice," Cell, 88:131-141 (1997).
Lee et al., Cycloaddition of Homophthalic Anhydrides to Azodicarboxylate and Alkylidenecarbamates. Chemical Abstracts, 106(3):18331a (1987).
Ollman et al., "Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein," Science, 278:135-138 (1997).
Omholt et al., "Oral Formulation of the Heptapeptide HP 228 Modulates Inflammation and Resting Oxygen Consumption in the Mouse and Rat," The Pharmacologist, 39(1):29, Abstract 53 (1997).
Ostresh et al., "Libraries from libraries: Chemical transformation of combinatorial libraries to extend the range and repertoire of chemical diversity." Proc. Natl. Acad. Sci. USA, 91:11138-11142 (1994).
Platzer et al., "Up-regulation of monocytic IL-10 by tumor necrosis factor-.alpha. and cAMP elevating drugs," International Immunology, 7(4)517-523 (1995).
Schioth et al., "Characterization of the binding of MSH-B, HP-228, GHRP-6 and 153N-6 to the human melanocortin receptor subtypes," Neuropeptides 31:565-571 (1997).
Smith et al., "Synthetic approaches to hexahydropyrrolo[1,2-b]isoquinolones." J. Heterocyclic Chem., 26:1815-1817 (1989).
Smith and Atigadda, "Condensation of homophthalic anhydrides with heterocyclic imines and DMAD under mild conditions." J. Heterocyclic Chem., 28:1813-1815 (1991).
Star et al., "Evidence of autocrine modulation of macrophage nitric oxide synthase by .alpha.-melanocyte-stimulating hormone," Proc. Natl. Acad. Sci. USA, 92:8016-8020 (1995).
Tamura et al., "Strong base induced cycloaddition of homophthalic anhydrides leading to peri-hydroxy polycyclic compounds." J. Org. Chem., 49:473-478 (1984).
Tamura et al., "Cycloaddition of homophthalic anhydride: A new and simple route to linearly condensed phenolic compounds." Tetrahedron Letters, 22(43):4283-4286 (1981).
Tatro, "Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides," Neuroimmunomodulation, 3:259-284 (1996).
Wenker, Henry, "Syntheses from ethanolamine. V. Synthesis of .increment.-Oxazoline and of 2,2'-.increment..sup.2 -Di-oxazoline." J. of Am. Chem. Society, 60(8):2152-2153 (1938).
Xia et al., "Expression of melanocortin 1 receptor in periaqueductal gray matter," Neuroreport, 6:2193-2196 (1995).
Basu Amaresh
Gahman Timothy C.
Girten Beverly E.
Griffith Michael C.
Hecht Curtis C.
McKane Joseph
Solola Taofiq A.
LandOfFree
Isoquinoline compound melanocortin receptor ligands and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isoquinoline compound melanocortin receptor ligands and methods , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoquinoline compound melanocortin receptor ligands and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-195987